Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)

Condition:   MalariaInterventions:   Drug: Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine;   Drug: Artemether-Lumefantrine (AL) combination;   Drug: Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquineSponsors:   London School of Hygiene and Tropical Medicine;   Centre National de Recherche et de Formation sur le Paludisme, Burkina Faso;   University Medical Center NijmegenNot yet recruiting - verified June 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials